Conference Call Notice - MIGENIX First Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification

Conference Call Notice - MIGENIX First Quarter Fiscal 2006 Financial Results Conference Call & Web Cast Notification

Wednesday, September 7, 2005 - 11:00 a.m. ET; 8:00 a.m. PT

VANCOUVER and SAN DIEGO, CA, Sept. 2 /PRNewswire-FirstCall/ -- MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious and degenerative diseases, will host a conference call and web cast on Wednesday, September 7, 2005 at 11:00 a.m. ET (8:00 a.m. PT) to discuss financial results for the first quarter of fiscal year 2006 ended July 31, 2005 and provide an update on company activities. To participate in the conference call, please dial 416-640-4127 or 1-800-814-3911. The call will be available for replay until September 21, 2005 by calling 416-640-1917 or 1-877- 289-8525 and entering the pass code 21151232. The live and archived web cast can be accessed through the company's website at www.migenix.com.

About MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs in the areas of infectious and degenerative diseases. The Company's clinical programs include drug candidates for the treatment of chronic Hepatitis C infections (Phase II), the prevention of catheter-related infections (Phase III), the treatment of neurodegenerative diseases (Phase I) and the treatment of acne (Phase II). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. Additional information can be found at www.migenix.com.

CONTACTS
Jonathan Burke Dian Griesel, Ph.D.
MIGENIX Inc. Investor Relations Group
Tel: (604) 221-9666 Tel: (212) 825-3210
Extension 241 Theproteam@aol.comjburke@migenix.com

The Toronto Stock Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.

Source: MIGENIX Inc.

CONTACT: Jonathan Burke, MIGENIX Inc., Tel: (604) 221-9666, Extension
241, jburke@migenix.com; Dian Griesel, Ph.D., Investor Relations Group,
Tel: (212) 825-3210, Theproteam@aol.com;
To request a free copy of this organization's annual report, please go to
http://www.newswire.ca/ and click on reports@cnw.

-------
Profile: jene39